文献速递妇科

卵巢癌二次减瘤术中预测完全肉眼切除的模型比较分析

A comparative analysis of prediction models for complete gross resection in secondary cytoreductive surgery for ovarian cancer.
PubMed 文献 · Gynecol Oncol · 2017-03-09

该研究分析了214例铂敏感复发卵巢癌二次减瘤术病例,评估纪念斯隆凯特琳(MSK)标准预测完全肉眼切除(CGR)的依从性与结局,并与已验证的Tian和AGO模型比较。实施MSK标准后CGR率为86%;Tian模型准确率88%,AGO模型49%;Tian与MSK模型一致性检验McNemar P=0.366,AGO与MSK标准间P<0.001。CGR与更长PFS和OS相关。

要点

  • 实施MSK标准后二次减瘤术CGR率达86%。
  • Tian模型预测CGR准确率88%,AGO模型49%。
  • Tian与MSK模型一致性良好(McNemar P=0.366)。

核心结论

  • 二次减瘤术中实现CGR与延长的PFS和OS相关。
  • 使用MSK标准报告了高CGR率。
  • Tian与MSK模型间一致性良好;后者变量更少且更易用。
  • Tian标准可应用于MSK中间病例以进一步分层。

研究设计与样本

  • 研究纳入2001年5月至2014年6月间因铂敏感复发卵巢癌接受二次减瘤术的患者。
  • 共识别214例二次减瘤术病例。
  • 将AGO和Tian模型应用于研究人群,采用适当统计检验评估预测CGR的能力。

主要发现

  • 自实施MSK标准以来,CGR率为86%。
  • AGO模型预测CGR准确率为49%,预测肉眼残留病灶(RD)占51%;但实际86%达到CGR。
  • Tian模型准确率为88%;评为Tian高风险肉眼RD的4%中,33%达到CGR。
  • Tian与MSK模型比较McNemar P=0.366;AGO与MSK标准比较P<0.001。
  • 全队列、达到CGR者、残留RD者的中位PFS分别为21.3个月(95%CI 18.2-24.5)、22.5个月(95%CI 19.4-25.3)、14.1个月(95%CI 9.7-22.1),P=0.013;中位OS分别为82.2个月(95%CI 60.2-123.3)、95.6个月(95%CI 63.6-未估计)、57.5个月(95%CI 27.5-113.9),P=0.014。

临床怎么用

  • 作者报告使用MSK标准可获得高CGR率。
  • 作者认为Tian与MSK模型一致性良好,后者变量更少且更易用。
  • 作者提出Tian标准可应用于MSK中间病例以进一步分层。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We sought to examine compliance and outcomes using Memorial Sloan Kettering "(MSK) criteria" to predict complete gross resection (CGR) and compare them with the validated Tian and AGO models. METHODS: Patients who underwent SCS for recurrent platinum-sensitive ovarian cancer from 5/2001-6/2014 were identified. The AGO and Tian models were applied to the study population; appropriate statistical tests were used to determine ability to predict CGR. RESULTS: 214 SCS cases were identified. Since the implementation of MSK criteria, the CGR rate has been 86%. The AGO model had a 49% accuracy rate in predicting CGR, and predicted gross residual disease (RD) in 51%; however, CGR was achieved in 86%. The Tian model had an 88% accuracy rate. Of the 4% scored as Tian high risk for gross RD, 33% achieved a CGR. Comparing models, McNemar's p-value was 0.366 between the Tian and MSK models and <0.001 between AGO and MSK criteria. Median PFS was 21.3 (95%CI, 18.2-24.5), 22.5 (95%CI, 19.4-25.3), and 14.1months (95%CI, 9.7-22.1) for the entire cohort, for those achieving CGR, and for those left with RD, respectively (p=0.013). OS was 82.2 (95%CI, 60.2-123.3), 95.6 (95%CI, 63.6-NE), and 57.5months (95%CI, 27.5-113.9), respectively (p=0.014). CONCLUSION: CGR during SCS is associated with extended PFS and OS. We report a high rate of CGR using MSK criteria. There was good concordance between the Tian and MSK models; however, the latter has fewer variables and is more user-friendly. Tian criteria may be applied to intermediate MSK cases for further stratification.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Cowan RA, Eriksson AGZ, Jaber SM, et al. A comparative analysis of prediction models for complete gross resection in secondary cytoreductive surgery for ovarian cancer. Gynecol Oncol. 2017. PMID: 28285846. doi:10.1016/j.ygyno.2017.02.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。